Modern Cannabis Is Hitting Gen Z Mental Health Hard – Neuroscience News

WHY IT MATTERS: Young people who use high-potency cannabis products frequently should understand that their risk for developing or worsening anxiety and depression is meaningfully elevated compared to non-users or infrequent users, and that risk increases the earlier in adolescence use begins. CLINICAL OVERVIEW: The relationship between high-potency cannabis and mental health conditions such as anxiety and depression is not incidental, and the shift toward products with dramatically elevated THC concentrations over recent decades has outpaced what most young developing brains can tolerate without consequence. Gen Z has grown up with near-unrestricted access to concentrates, vape cartridges, and edibles that bear little resemblance to the cannabis of prior generations, making direct comparisons across age cohorts scientifically problematic but still clinically instructive.

Read More

420 with CNW โ€” Study Links Psychiatric Disorders to Adolescent Cannabis Use

WHY IT MATTERS: If you are a parent or caregiver of a teenager, this research underscores why adolescent cannabis use should only occur under direct medical supervision with careful psychiatric screening, and why recreational or unsupervised use during brain development carries meaningful risk. CLINICAL OVERVIEW: Research continues to explore the association between adolescent cannabis use and the development of psychiatric disorders, including psychosis, depression, and bipolar spectrum conditions. While these correlational findings are important to acknowledge, clinicians must also consider confounding variables such as pre-existing mental health conditions, adverse childhood experiences, genetic predisposition, and the role of self-medication that may drive early cannabis use in vulnerable youth.

Read More

Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape

WHY IT MATTERS: If you are a parent or caregiver of a teen, or a young person using cannabis yourself, this research reinforces that delaying use until the brain is more fully developed, typically into the mid-20s, is one of the most important harm reduction strategies available. CLINICAL OVERVIEW: Emerging research continues to reinforce what clinicians have observed for years: adolescent cannabis use, particularly during critical neurodevelopmental windows, is associated with a meaningful increase in risk for serious psychiatric conditions including psychotic and bipolar disorders. The developing brain remains uniquely vulnerable to exogenous cannabinoids, and the endocannabinoid system plays a central role in synaptic pruning and neural circuit maturation during the teenage years.

Read More

A huge study finds a link between cannabis use in teens and psychosis later – KUOW

WHY IT MATTERS: If you are a parent, caregiver, or young adult considering cannabis use, this research reinforces that delaying use until the brain is more fully developed, generally past age 25, is one of the most important harm reduction strategies available. CLINICAL OVERVIEW: Large-scale longitudinal research continues to reinforce the clinical concern that adolescent cannabis exposure is associated with elevated risk of psychotic disorders and other serious mental health conditions in adulthood. From a neurobiological standpoint, the adolescent brain is undergoing critical endocannabinoid system maturation, and exogenous cannabinoid exposure during this window may disrupt neurodevelopmental trajectories in ways that increase vulnerability to psychosis, particularly in genetically predisposed individuals.

Read More

Teens Using Weed Have Doubled Risk For Psychosis, Bipolar Disorder

New research is sounding the alarm on teen cannabis use and mental health risk. Here’s what you need to know: Study tracked teens through age 26 Results showed doubled risk for psychosis and bipolar disorder in teen users ๏ธ The developing brain is uniquely vulnerable to THC exposure โ€๏ธ This is why cannabis medicine physicians distinguish between adult therapeutic use and adolescent recreational use ๏ธ Age-appropriate care matters As a physician who has treated over 30,000 patients, I firmly believe cannabis has real medical value for adults. But that belief comes with a responsibility to be honest: the teen brain is still under construction, and we need to protect it. Talk to your kids. Talk to your doctor. Get the facts. New research links teen cannabis use to doubled psychosis and bipolar risk by age 26. The developing brain deserves different rules than the adult brain.

Read More

Study: Teen Cannabis Use Linked to Double Psychosis Risk – Ground News

New research links adolescent cannabis use to a significantly higher risk of psychosis. Here’s what you need to know: Teen cannabis use was associated with roughly 2x the risk of developing psychotic disorders Genetic predisposition and frequency of use likely play major roles ๏ธ The adolescent brain is still developing well into the mid-20s Medical cannabis programs screen for psychiatric risk factors for exactly this reason This is not about fear โ€” it’s about informed, age-appropriate decisions Cannabis can be powerful medicine for adults under proper guidance. But for teens, the risk-benefit equation is very different. Talk to your kids. Talk to your doctor. Knowledge is harm reduction. New study links teen cannabis use to doubled psychosis risk. This is why age, dose, and clinical oversight matter.

Read More

Study: Teen Cannabis Use Linked to Double Psychosis Risk

This is one of the largest studies ever conducted on teen cannabis use and psychiatric outcomes, and it reinforces that age restrictions and youth prevention should be central to any legalization framework. A JAMA Health Forum study of 463,396 adolescents ages 13 to 17 found cannabis use was linked to a twofold increase in psychotic and bipolar disorder risk by age 26. The study represents one of the largest longitudinal investigations of this association, drawing on clinical health records rather than self-reported data.

Read More

Cannabis Use by Teenagers Doubles Their Risk of Developing Psychotic and Bipolar Disorders

With cannabis potency at historic highs, this study underscores that adolescent brains are uniquely vulnerable to THC exposure, and parents should understand the psychiatric risks before dismissing cannabis as harmless. Data from a JAMA Health Forum study of nearly half a million teenagers demonstrates that adolescent cannabis use doubles the risk of psychotic and bipolar disorder diagnoses by early adulthood. The association persisted across demographic subgroups and was temporally consistent, with cannabis use preceding psychiatric diagnoses by roughly two years on average.

Read More

Adolescent Cannabis Use Linked to Doubling Risk of Psychotic and Bipolar Disorders

Nearly half a million teens were tracked in this study, and the data shows cannabis use during adolescence meaningfully increases the chance of serious psychiatric diagnoses in early adulthood. A large longitudinal cohort study published in JAMA Health Forum tracked 463,396 adolescents and found that cannabis use between ages 13 and 17 was associated with approximately double the risk of psychotic and bipolar disorders by age 26. Elevated risks for depression and anxiety were also observed.

Read More